2018 Global Drug-Eluting Coating Industry Report - History, Present and Future

November 2018 | 144 pages | ID: 28E90421A73EN
Prof Research

Abstracts

The global market size of Drug-Eluting Coating is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:

• North America
• South America
• Asia & Pacific
• Europe
• MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Drug-Eluting Coating as well as some small players. The compnaies include:

Armoloy of Connecticut, Inc. (US), AST Products, Inc. (US), Biocoat, Inc. (US), Biophan Technologies, Inc. (US), Carmeda AB (Sweden), Covalon Technologies Ltd. (Canada), Hemoteq AG (Germany), Hydromer et al.

The information for each competitor includes:

• Company Profile
• Main Business Information
• SWOT Analysis
• Sales, Revenue, Price and Gross Margin
• Market Share

We also can offer customized report to fulfill special requirements of our clients.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Drug-Eluting Coating Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Drug-Eluting Coating by Region
8.2 Import of Drug-Eluting Coating by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT DRUG-ELUTING COATING MARKET IN NORTH AMERICA (2013-2018)

9.1 Drug-Eluting Coating Supply
9.2 Drug-Eluting Coating Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT DRUG-ELUTING COATING MARKET IN SOUTH AMERICA (2013-2018)

10.1 Drug-Eluting Coating Supply
10.2 Drug-Eluting Coating Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT DRUG-ELUTING COATING MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Drug-Eluting Coating Supply
11.2 Drug-Eluting Coating Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT DRUG-ELUTING COATING MARKET IN EUROPE (2013-2018)

12.1 Drug-Eluting Coating Supply
12.2 Drug-Eluting Coating Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT DRUG-ELUTING COATING MARKET IN MEA (2013-2018)

13.1 Drug-Eluting Coating Supply
13.2 Drug-Eluting Coating Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL DRUG-ELUTING COATING MARKET (2013-2018)

14.1 Drug-Eluting Coating Supply
14.2 Drug-Eluting Coating Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL DRUG-ELUTING COATING MARKET FORECAST (2019-2023)

15.1 Drug-Eluting Coating Supply Forecast
15.2 Drug-Eluting Coating Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(ARMOLOY OF CONNECTICUT, INC. (US), AST PRODUCTS, INC. (US), BIOCOAT, INC. (US), BIOPHAN TECHNOLOGIES, INC. (US), CARMEDA AB (SWEDEN), COVALON TECHNOLOGIES LTD. (CANADA), HEMOTEQ AG (GERMANY), HYDROMER ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Drug-Eluting Coating Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Drug-Eluting Coating Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Drug-Eluting Coating Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Drug-Eluting Coating Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Drug-Eluting Coating Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Drug-Eluting Coating Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Drug-Eluting Coating Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2013-2018)

Tables & Figures

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Drug-Eluting Coating Report
Table Primary Sources of Drug-Eluting Coating Report
Table Secondary Sources of Drug-Eluting Coating Report
Table Major Assumptions of Drug-Eluting Coating Report
Figure Drug-Eluting Coating Picture
Table Drug-Eluting Coating Classification
Table Drug-Eluting Coating Applications List
Table Drivers of Drug-Eluting Coating Market
Table Restraints of Drug-Eluting Coating Market
Table Opportunities of Drug-Eluting Coating Market
Table Threats of Drug-Eluting Coating Market
Table Key Raw Material of Drug-Eluting Coating and Its Suppliers
Table Key Technologies of Drug-Eluting Coating
Table Cost Structure of Drug-Eluting Coating
Table Market Channel of Drug-Eluting Coating
Table Drug-Eluting Coating Application and Key End Users List
Table Latest News of Drug-Eluting Coating Industry
Table Recently Merger and Acquisition List of Drug-Eluting Coating Industry
Table Recently Planned/Future Project List of Drug-Eluting Coating Industry
Table Policy Dynamics Update of Drug-Eluting Coating Industry
Table 2013-2023 Export of Drug-Eluting Coating by Region
Table 2013-2023 Import of Drug-Eluting Coating by Region
Table 2013-2023 Balance of Trade of Drug-Eluting Coating
Figure 2013 2018 and 2023 Global Trade Map of Drug-Eluting Coating
Table 2013-2018 North America Supply of Drug-Eluting Coating
Figure 2013-2018 North America Drug-Eluting Coating Supply and GAGR
Table 2013-2018 North America Drug-Eluting Coating Downstream Demand List
Figure 2013-2018 North America Drug-Eluting Coating Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Drug-Eluting Coating Demand by Type
Figure 2013-2018 North America Drug-Eluting Coating Price
Table 2013-2018 Key Countries Supply of Drug-Eluting Coating in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Drug-Eluting Coating in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Drug-Eluting Coating
Figure 2013-2018 South America Drug-Eluting Coating Supply and GAGR
Table 2013-2018 South America Drug-Eluting Coating Downstream Demand List
Figure 2013-2018 South America Drug-Eluting Coating Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Drug-Eluting Coating Demand by Type
Figure 2013-2018 South America Drug-Eluting Coating Price
Table 2013-2018 Key Countries Supply of Drug-Eluting Coating in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Drug-Eluting Coating in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Drug-Eluting Coating
Figure 2013-2018 Asia & Pacific Drug-Eluting Coating Supply and GAGR
Table 2013-2018 Asia & Pacific Drug-Eluting Coating Downstream Demand List
Figure 2013-2018 Asia & Pacific Drug-Eluting Coating Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Drug-Eluting Coating Demand by Type
Figure 2013-2018 Asia & Pacific Drug-Eluting Coating Price
Table 2013-2018 Key Countries Supply of Drug-Eluting Coating in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Drug-Eluting Coating in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Drug-Eluting Coating
Figure 2013-2018 Europe Drug-Eluting Coating Supply and GAGR
Table 2013-2018 Europe Drug-Eluting Coating Downstream Demand List
Figure 2013-2018 Europe Drug-Eluting Coating Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Drug-Eluting Coating Demand by Type
Figure 2013-2018 Europe Drug-Eluting Coating Price
Table 2013-2018 Key Countries Supply of Drug-Eluting Coating in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Drug-Eluting Coating in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Drug-Eluting Coating
Figure 2013-2018 MEA Drug-Eluting Coating Supply and GAGR
Table 2013-2018 MEA Drug-Eluting Coating Downstream Demand List
Figure 2013-2018 MEA Drug-Eluting Coating Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Drug-Eluting Coating Demand by Type
Figure 2013-2018 MEA Drug-Eluting Coating Price
Table 2013-2018 Key Countries Supply of Drug-Eluting Coating in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Drug-Eluting Coating in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Drug-Eluting Coating by Region
Figure 2013-2018 Global Supply and CAGR of Drug-Eluting Coating by Region
Table 2013-2018 Global Drug-Eluting Coating Downstream Demand List by Region
Figure 2013-2018 Global Drug-Eluting Coating Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Drug-Eluting Coating Type-wise Demand by Region
Figure 2013-2018 Global Drug-Eluting Coating Price
Table Main Business and Drug-Eluting Coating Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Drug-Eluting Coating Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Drug-Eluting Coating Sales Revenue and Growth Rate
Figure 2013-2018 Company A Drug-Eluting Coating Market Share
Table Main Business and Drug-Eluting Coating Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Drug-Eluting Coating Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Drug-Eluting Coating Sales Revenue and Growth Rate
Figure 2013-2018 Company B Drug-Eluting Coating Market Share
Table Main Business and Drug-Eluting Coating Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Drug-Eluting Coating Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Drug-Eluting Coating Sales Revenue and Growth Rate
Figure 2013-2018 Company C Drug-Eluting Coating Market Share
Table Main Business and Drug-Eluting Coating Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Drug-Eluting Coating Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Drug-Eluting Coating Sales Revenue and Growth Rate
Figure 2013-2018 Company D Drug-Eluting Coating Market Share
Table Main Business and Drug-Eluting Coating Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Drug-Eluting Coating Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Drug-Eluting Coating Sales Revenue and Growth Rate
Figure 2013-2018 Company E Drug-Eluting Coating Market Share
Table Main Business and Drug-Eluting Coating Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Drug-Eluting Coating Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Drug-Eluting Coating Sales Revenue and Growth Rate
Figure 2013-2018 Company F Drug-Eluting Coating Market Share
Table Main Business and Drug-Eluting Coating Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Drug-Eluting Coating Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Drug-Eluting Coating Sales Revenue and Growth Rate
Figure 2013-2018 Company G Drug-Eluting Coating Market Share